678 results on '"Arat, Mutlu"'
Search Results
202. The Impact of Methylenetetrahydrofolate Reductase C677T Gene Polymorphism on Engraftment after Allogeneic Hematopoetic Cell Transplantation.
203. A New Predictive and Prognostic Marker for De Novo AML: Peripheral Blood CD34 (pCD34) Count at Recovery Following Remission Induction (RI) Therapy (Supp. by Ankara University-2003-0809114).
204. Trefoil Factor Expression in Biliary Epithelium of Graft-versus-Host Disease of the Liver after Allogeneic Hematopoietic Cell Transplantation
205. Allogeneic Hemapoietic Progenitor Cell Collection Using Four Different Cell Separators: A Retrospective Comparative Analysis.
206. The Comparison of Myeloablative Versus Reduced Intensity Conditioning Regimen in ABO Mismatched Allogeneic Hematopoietic Cell Transplantation.
207. Both Higher Level of (bcr,abl) Transcripts and High Hasford Risk Score Are Associated with Cytogenetic Response but Absence of Molecular Remission during First Line Use of Imatinib Mesilate(IM): A Finding Not Observed Following Use among Interferon Failures.
208. Bone Marrow Microvessel Density (MVD) in Adult Acute Myeloid Leukemia (AML): Therapy Induced Changes and Effects on Survival
209. Effects of Replacement Fluids on Plasma Viscosity Used for Therapeutic Plasma Exchange
210. Simultaneous Onset of Chronic Graft Versus Host Disease and Alopecia Areata Following Allogeneic Haematopoietic Cell Transplantation
211. Dermatomal lichenoid graft‐versus‐host disease within herpes zoster scars
212. Fatal fulminant hepatic failure during treatment of multiple myeloma Multipl myeloma tedavisi sırasında ölümcül fulminan karaciğeryetmezliği
213. An Unusual Presentation of Plasma Cell Dyscrasias: Cardiac Tamponade due to Myelomatous Infiltration
214. Treatment of extensive chronic sclerodermatous graft-versus-host disease with high-dose immunosuppressive therapy and CD34+ autologous stem cell rescue
215. Hematopoietic cell transplantation-related nephropathy
216. Circulating CD44 and intercellular adhesion molecule-1 levels in low grade non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia patients during interferon-?-2a treatment
217. Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center.
218. Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft verses host disease
219. Treatment of Aregeneratoric Anemia Following an ABO‐Incompatible Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report
220. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma
221. Allogeneic peripheral blood stem cell transplantation in acute non-lymphoblastic leukemia
222. Randomised unicenter trial for comparison of three regimens inde novo adult acute nonlymphoblastic leukaemia
223. Use of High-Dose Chemotherapy plus Granulocyte Colony-Stimulating Factor for the Salvage of Refractory or Resistant-Relapse Lymphoma Patients without Stem Cell Support
224. Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
225. Increase of suicide and accidental death after hematopoietic stem cell transplantation Increase of suicide and accidental death after hematopoietic stem cell transplantation: A cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
226. Intramesenteric Steroid Treatment for Steroid-Refractory Gastrointestinal Graft Versus Host Disease.
227. Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patients.
228. Lymphoproliferative disorders in individuals with chronic hepatitis b and C in the Turkish population.
229. Clinical aspects of sclerodermatous type graft-versushost disease after allogeneic hematopoietic cell transplantation.
230. Hepatic complications of allogeneic hematopoietic cell transplantation.
231. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience.
232. Clonal evolution of monosomy 7 in acquired severe aplastic anemia: Two cases treated with allogeneic hematopoietic stem cell transplantation.
233. T-helper-1 (Th1) and Th2 cytokines after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
234. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
235. Serum transforming growth factor beta 1 levels in multiple myeloma patients.
236. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
237. The effect of a nationwide antibiotic restriction policy on antibiotic usage in a stem cell transplantation unit.
238. Clinical Manifestations of Cutaneous Graft-versus-host Disease after Allogeneic Haematopoietic Cell Transplantation: Long-term Follow-up Results in a Single Turkish Centre.
239. Therapeutic plasma exchange in a single center: Ibni Sina experience
240. Hb content-based transfusion policy successfully reduces the number of RBC units transfused.
241. Report Evaluation of nail involvement in patients with chronic cutaneous graft versus host disease: A single-center study from Turkey.
242. Therapeutic Angiogenesis by Autologous Transplantation of Bone-Marrow Mononuclear Cells for Buerger's Patients with Retractable Limb Ischaemia: A Preliminary Report.
243. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy
244. Autologous Platelet Collection and Storage to Support Thrombocytopenia in a Leukemia Patient with Platelet Alloimmunization Undergoing Chemotherapy.
245. Therapeutic Plasma Exchange and the Clinical Applications.
246. The Role of ABO Incompatibility in Allogeneic Peripheral Blood Stem Cell Transplantation.
247. A Case of Catheter Related Septicemia Caused by Corynebacterium jeikeium.
248. The Incidence of Hepatitis G Virus in Patients with Hematological Malignancies: The Relationship to the Number of Blood and Blood Products Transfusions.
249. Non-T-Cell Depleted Haploidentical Stem Cell Transplantation (haploHCT) with Post Transplantation Cyclophosphamide (PTCy)- the Role of Donor Kinship: From the ALWP of the EBMT
250. MRD Status Impact on Secondary Acute Myeloid Leukemia Outcomes after Allogeneic Hematopoietic Cell Transplantation. A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.